Correction of Author Attribution in the Study on Oral versus Intravenous Antibiotics
Background
Accurate author attribution is crucial in clinical research to ensure proper credit and accountability. The POvIV trial evaluates treatment options for fracture-related infections, a common complication in trauma care. Understanding the efficacy of oral versus intravenous antibiotics is essential.
Data Highlights
No numerical data or trial results are presented in the correction notice.
Key Findings
- The POvIV trial compared oral and intravenous antibiotics for fracture-related infections.
- The correction involved adding eight authors to the byline of the original publication.
- Accurate authorship is essential for maintaining the integrity of clinical research.
- Related articles highlight the importance of proper attribution and corrections in published studies.
Clinical Implications
This correction highlights the need for accurate author attribution in research publications.
Conclusion
The correction of author attribution in the POvIV trial is a necessary step in maintaining accuracy in clinical research publications.
Related Resources & Content
- Oral vs Intravenous Antibiotics for Fracture-Related Infections: The POvIV Randomized Clinical Trial, JAMA Surgery, 2025 -- Correction of Author Attribution
- Intensive Care Medicine — Correction Notice: Impact of Daily Antiseptic Bathing with Octenidine on Bacteremia and Multidrug-Resistant Organisms Acquired in the ICU: A Multicenter, Cluster-Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
- Infection — Correction Notice: Assessment of Systemic Inflammatory Response After Transcatheter Aortic Valve Replacement: A Framework for Judicious Antibiotic Administration
- Infection — Amendment to: Clinical Insights on Dalbavancin Use for Gram-Positive Skin and Soft Tissue Infections, as well as Bone and Joint Infections
- Infection — Amendment: Utilization of cefiderocol in a challenging case of extensively drug-resistant Acinetobacter baumannii infection associated with fractures: An integrated and multidisciplinary treatment strategy
- Oral vs Intravenous Antibiotics for Fracture-Related Infections: The POvIV Randomized Clinical Trial
- Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT - PMC
- Checking your browser - reCAPTCHA
- Early oral versus prolonged intravenous antimicrobial treatment in children with bone and joint infections: a systematic review and meta-analysis - PubMed
- Implementation of oral versus intravenous antibiotics in clinical practice at a specialized orthopedic infection unit: a descriptive retrospective cohort study - PubMed
- Recommendations for Systemic Antimicrobial Therapy in Fracture-Related Infection: A Consensus From an International Expert Group - PMC
- JBJI - Twenty common errors in the prevention, diagnosis, and treatment of fracture-related infection (FRI)
- Optimizing Antibiotic Therapy in Musculoskeletal Infections - PubMed
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
